10/01/2025
4:22 PM | Chen Bihua (Reporting)
Cormorant Asset Management, LP (Reporting)
Cormorant Global Healthcare Master Fund, LP (Reporting)
Cormorant Private Healthcare Fund II, LP (Reporting)
Cormorant Private Healthcare Fund III LP (Reporting)
Cormorant Private Healthcare Fund IV LP (Reporting)
MoonLake Immunotherapeutics (Issuer)
MoonLake Immunotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2025
4:23 PM | Chen Bihua (Filed by)
MoonLake Immunotherapeutics (Subject)
MoonLake Immunotherapeutics (Subject)
| Form SCHEDULE 13G/A | |
09/29/2025
6:15 AM | MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/04/2025
3:01 PM | MoonLake Immunotherapeutics (Issuer)
MoonLake Immunotherapeutics (Issuer)
Reich Kristian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2025
5:57 AM | Avoro Capital Advisors LLC (Filed by)
MoonLake Immunotherapeutics (Subject)
MoonLake Immunotherapeutics (Subject)
| Form SCHEDULE 13G | |
08/05/2025
6:01 AM | MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/05/2025
6:04 AM | MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/03/2025
12:23 PM | MoonLake Immunotherapeutics (Subject)
MoonLake Immunotherapeutics (Subject)
Moukheibir Catherine (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2025
6:16 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
MoonLake Immunotherapeutics (Issuer)
MoonLake Immunotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
8:05 AM | MoonLake Immunotherapeutics (Issuer)
MoonLake Immunotherapeutics (Issuer)
Phillips Andrew John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
8:06 AM | MoonLake Immunotherapeutics (Issuer)
MoonLake Immunotherapeutics (Issuer)
Moukheibir Catherine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for MLTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for MoonLake Immunotherapeutics and its competitors with MarketBeat's FREE daily newsletter. |
06/09/2025
8:07 AM | MoonLake Immunotherapeutics (Issuer)
MoonLake Immunotherapeutics (Issuer)
Xavier Ramnik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
8:07 AM | Loy Spike (Reporting)
MoonLake Immunotherapeutics (Issuer)
MoonLake Immunotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
8:08 AM | MoonLake Immunotherapeutics (Issuer)
MoonLake Immunotherapeutics (Issuer)
Sturge Simon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
3:30 PM | MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2025
9:45 AM | MoonLake Immunotherapeutics (Subject)
MoonLake Immunotherapeutics (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
| Form SCHEDULE 13G/A | |
04/29/2025
6:05 AM | MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/22/2025
3:30 PM | MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
| Form DEF 14A | |
04/22/2025
3:34 PM | MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
| Form DEFA14A | |
04/22/2025
3:36 PM | MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
| Form ARS | |
04/03/2025
6:05 AM | MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/03/2025
8:06 PM | Bodenstedt Matthias (Reporting)
MoonLake Immunotherapeutics (Issuer)
MoonLake Immunotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
8:07 PM | MoonLake Immunotherapeutics (Issuer)
MoonLake Immunotherapeutics (Issuer)
Reich Kristian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
8:08 PM | MoonLake Immunotherapeutics (Issuer)
MoonLake Immunotherapeutics (Issuer)
Santos da Silva Jorge (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
6:09 AM | MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2025
6:13 AM | MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2025
8:44 AM | MoonLake Immunotherapeutics (Subject)
MoonLake Immunotherapeutics (Subject)
| Form SCHEDULE 13G | |
02/12/2025
8:30 AM | FMR LLC (Filed by)
MoonLake Immunotherapeutics (Subject)
MoonLake Immunotherapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/22/2025
8:55 PM | MoonLake Immunotherapeutics (Issuer)
MoonLake Immunotherapeutics (Issuer)
Reich Kristian (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2024
3:30 PM | MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
6:03 AM | MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2024
6:05 AM | MoonLake Immunotherapeutics (Filer)
MoonLake Immunotherapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/08/2024
5:48 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
MoonLake Immunotherapeutics (Subject)
MoonLake Immunotherapeutics (Subject)
| Form SC 13D/A | |
10/08/2024
5:50 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
MoonLake Immunotherapeutics (Issuer)
MoonLake Immunotherapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
